Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study

BRITISH JOURNAL OF DERMATOLOGY

WILEY-BLACKWELL

1. Bayer HealthCare, AG
2. KYTHERA Biopharmaceuticals, Inc.